Fingerprint
Dive into the research topics of 'CYP2C8*3 predicts benefit/risk profile in breast cancer patients receiving neoadjuvant paclitaxel'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
CYP2C8*3 predicts benefit/risk profile in breast cancer patients receiving neoadjuvant paclitaxel
Daniel L. Hertz, Alison A. Motsinger-Reif, Amy Drobish, Stacey J. Winham, Howard L. McLeod, Lisa A. Carey, E. Claire Dees
Research output: Contribution to journal › Article › peer-review
65
Scopus
citations